Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Colloids and Surfaces. B, Biointerfaces|December 12, 2018
Co-delivery of paclitaxel and doxorubicin using mixed micelles based on the redox sensitive prodrugsMin Yang, Houqiang Ding, Yixin Zhu, et al.
European Journal of Medicinal Chemistry|February 21, 2021
Preparation and in vitro evaluation of amphiphilic paclitaxel small molecule prodrugs and enhancement of oral absorptionYuanyuan Li, Min Yang, Yanli Zhao, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 30, 2020
Redox- and MMP-2-sensitive drug delivery nanoparticles based on gelatin and albumin for tumor targeted delivery of paclitaxelKe Zhou, Yixin Zhu, Xuling Chen, et al.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|August 24, 2007
[The drug release properties of poly (acrylamide-co-itaconate-vinylbenzylglycosylallylamide) hydrogels]Yanwei Xi, Lingbing Li, Yebang Tan, et al.
Materials Science & Engineering. C, Materials for Biological Applications|March 1, 2019
Preparation and evaluation of highly biocompatible nanogels with pH-sensitive charge-convertible capability based on doxorubicin prodrugYixin Zhu, Yakun Ma, Yanli Zhao, et al.
Carbohydrate Polymers|January 13, 2021
Redox-responsive nanoparticles based on Chondroitin Sulfate and Docetaxel prodrug for tumor targeted delivery of DocetaxelYimu Li, Xuling Chen, Jianbo Ji, et al.
Colloids and Surfaces. B, Biointerfaces|January 25, 2022
A novel multifunctional nanoparticles formed by molecular recognition between AS1411 aptamer and redox-responsive paclitaxel-nucleoside analogue prodrug for combination treatment of β-lapachone and paclitaxelXuling Chen, Jianbo Ji, Ke Zhou, et al.
Journal of Biomedical Nanotechnology|June 29, 2019
The Study of Tacrolimus-Loaded Polyion Complex Micelles for Oral DeliveryYan Chen, Yan Jiao, Yanxiu Ge, et al.
Current Research in Toxicology|October 13, 2025
GenX induces offspring vascular endothelial ferroptosis by targeting GPX4 for ubiquitination-dependent degradationJing Li, Yuhui Cui, Chengyi Zheng, et al.
Drug Development and Industrial Pharmacy|December 29, 2025
Construction of albumin based nanoparticles utilizing paclitaxel-fatty acid prodrug that mimicking the natural fatty-acid binding process <i>in vivo</i> to synergistically elevate ROS withβ-lapachone for cooperative cancer therapyYanli Zhao, Yimu Li, Yan Chen, et al.
Pageof 5